Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 5691
116th Congress(2019-2020)
Insulin Affordability Data Collection Act
Introduced
Introduced
Introduced in House on Jan 28, 2020
Overview
Text
Introduced in House 
Jan 28, 2020
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Jan 28, 2020)
Jan 28, 2020
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 5691 (Introduced-in-House)


116th CONGRESS
2d Session
H. R. 5691


To require the Secretary to conduct a study and issue a report on the affordability of insulin.

IN THE HOUSE OF REPRESENTATIVES

January 28, 2020

Ms. Craig (for herself, Mr. Guest, Mr. Stauber, and Mr. Phillips) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To require the Secretary to conduct a study and issue a report on the affordability of insulin.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Insulin Affordability Data Collection Act”.

SEC. 2. Study and report on the affordability of insulin.

The Secretary of Health and Human Services (referred to in this section as the “Secretary”), acting through the Assistant Secretary for Planning and Evaluation, shall—

(1) conduct a study that examines—

(A) for each type or classification of diabetes (including type 1 diabetes, type 2 diabetes, gestational diabetes, and other conditions causing reliance on insulin), the effect of the affordability of insulin on—

(i) adherence to insulin prescriptions;

(ii) rates of diabetic ketoacidosis;

(iii) downstream impacts of insulin adherence, including rates of dialysis treatment and end-stage renal disease;

(iv) spending by Federal health programs on acute episodes that could have been averted by adhering to an insulin prescription; and

(v) other factors, as appropriate, to understand the impacts of insulin affordability on health outcomes, Federal Government spending (including under the Medicare program under title XVIII of the Social Security Act (42 U.S.C. 1395 et seq.) and the Medicaid program under title XIX of the Social Security Act (42 U.S.C. 1396 et seq.)), and insured and uninsured individuals with diabetes; and

(B) among individuals who are unable to afford insulin, the numbers of such individuals—

(i) who are uninsured;

(ii) who are covered under private health insurance; and

(iii) who are covered under public health insurance programs; and

(2) not later than 2 years after the date of enactment of this Act, submit to Congress a report on the study conducted under paragraph (1).